Skip to main content
Premium Trial:

Request an Annual Quote

Jeff Elliott

Exact Sciences has appointed Jeff Elliott as vice president of business development and strategy. Effective June 20, Elliott will oversee the identification and pursuit of strategic business opportunities while also helping drive sales of Exact’s Cologuard colon cancer test. Most recently, Elliott worked as a senior research analyst covering the diagnostic and lab industries for Exact. He previously worked at Robert W. Baird as a senior research analyst covering diagnostics and life science tools companies. Elliott has also worked in a supply chain role for Walgreens and as a consultant at Cap Gemini Ernst & Young.

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.